Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04415866 · ClinicalTrials.gov registry record · NA

Generalized Hypersensitivity in Patients With Fibromyalgia Syndrome

A NA study of Fibromyalgia, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04415866 is a NA study of Fibromyalgia that has completed, run by University of Florida. The registered enrollment target is 30 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04415866, a NA study of Fibromyalgia, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Fibromyalgia (FM) is a chronic musculoskeletal pain disorder with unknown causes. Our previous studies showed abnormal sensations of second pain (wind-up), indicating central hypersensitivity as an important mechanism of FM. Triggering events have been implicated as the cause of central hypersensitivity.

Conditions Studied

Interventions

  • BEHAVIORAL Paced Auditory Serial Addition task (PASAT)

Study Locations (1)

Florida

  • University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-08-28
Est. Completion 2020-12-11
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT04415866

The ClinicalTrials.gov registry entry for NCT04415866 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (83% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Paced Auditory Serial Addition task (PASAT) is the first listed.

NCT04415866 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04415866 about?

NCT04415866 is a clinical study titled "Generalized Hypersensitivity in Patients With Fibromyalgia Syndrome". Fibromyalgia (FM) is a chronic musculoskeletal pain disorder with unknown causes. Our previous studies showed abnormal sensations of second pain (wind-up), indicating central hypersensitivity as an important mechanism of FM. Triggering events have been implicated as the cause of central hypersensiti...

What is the current status of trial NCT04415866?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-08-28. Estimated completion is 2020-12-11.

What conditions does trial NCT04415866 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT04415866?

The interventions under investigation include: Paced Auditory Serial Addition task (PASAT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04415866?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04415866 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.